Menu
1-702-720-6310 info@microcapspecualtors.com

Sarepta Therapeutics Announces Proposed Public Offering of Common Stock

[Business Wire] – Sarepta Therapeutics, Inc. , a developer of innovative RNA-targeted therapeutics, today announced that it is offering to sell, subject to market and other conditions, up to $225 million of its common stock in an underwritten public offering.
Source: New feed

Search